MedTrace Logo

The Role of Cobamamide Supplements in Malnourished Patients

NCT05944744 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 124

Last updated 2023-07-13

No results posted yet for this study

Summary

The trial is conducted to observe the effectiveness of cobamamide supplements in improving the clinical state malnourished patients.

Conditions

  • Malnutrition

Interventions

DRUG

Adenosylcobalamin

The drug contains Cobamamide / Adenosylcobalamin with dose of 3000 mg.

DRUG

Placebo

The drug doesn't contain any properties or substances for treatment.

Sponsors & Collaborators

  • Interbat Pharmaceuticals

    collaborator UNKNOWN

  • Fakultas Kedokteran Universitas Indonesia

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-07-31
Primary Completion
2024-07-31
Completion
2024-08-31

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05944744 on ClinicalTrials.gov